Gene · 9133
CCNB2: cyclin B2
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. CCNB2: cyclin B2. Genes, record 9133. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/9133
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| O95067 | G2/mitotic-specific cyclin-B2 | 398 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents59
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4650780 A2 | 2025-11-19 | 3364 | O95067 | Espacenet |
| EP 4641202 A2 | 2025-10-29 | 4692 | O95067 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 3364 | O95067 | Espacenet |
| KR 1020250017231 A | 2025-02-04 | 4692 | O95067 | Espacenet |
| JP 2024123008 A | 2024-09-10 | 5712 | O95067 | Espacenet |
| JP 2023123507 A | 2023-09-05 | 24 | O95067 | Espacenet |
| US 11708396 B2 | 2023-07-25 | 2172 | O95067 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 20981 | O95067 | Espacenet |
| JP 2022092366 A | 2022-06-22 | 809 | O95067 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 123952 | O95067 | Espacenet |
1 to 10 of 59
See all 59 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,401
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | CCNB2 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 8 | 2025 |
| P30CA076292 | Moffitt Cancer Center Support Grant | 7 | 2025 |
| P30CA015083 | Mayo Clinic Comprehensive Cancer Center Support Grant | 6 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 6 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 5 | 2025 |
| ZICES102445 | Gene Expression and Microarrays | 5 | 2025 |
| P30ES007033 | University of Washington Interdisciplinary Center for Exposures, Diseases, Genomics & Environment | 4 | 2025 |
| P50CA136393 | Use of microfluidic tumor cultures to enable clinical trials of therapies for ovarian cancer | 4 | 2025 |
| ZICHG200365 | NHGRI/DIR Microarray and single-cell Core | 4 | 2025 |
| P30CA014236 | Cancer Center Support Grant (CCSG) | 3 | 2025 |
1 to 10 of 1,401Source NIH's project files
See all 1,401 nih grantsPapers2,908
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| [Identification of immune key genes in sepsis and the regulatory effects of dexmedetomidine based on transcriptome analysis and machine learning]. | Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi | 2026 | 42750326 | PubTator, text mining | PubMed |
| Consensus subtypes and a generalizable prognostic signature defined by an R-loop score in hepatocellular carcinoma: Multi-omics analyses pinpoint KIF2A-positive proliferative tumor cells. | Pathol Res Pract | 2026 | 42636674 | PubTator, text mining | PubMed |
| A six-gene prognostic signature for aflatoxin B1-associated hepatocellular carcinoma identified through integrated bioinformatics and network toxicology. | Transl Gastroenterol Hepatol | 2026 | 42592322 | PubTator, text mining | PubMed |
| Adaptation of Non-Invasive Cancer Cells to 3D Collagen I Microenvironment Induces Transcriptional Reprogramming Accompanied by a More Complex RNA Landscape. | Int J Mol Sci | 2026 | 42589561 | PubTator, text mining | PubMed |
| Retraction Note: Knockdown of CCNB2 inhibits the tumorigenesis of gastric cancer by regulation of the PI3K/Akt pathway. | Sci Rep | 2026 | 42552334 | PubTator, text mining | PubMed |
| An Integrated Cellular Computational Pipeline Decodes Luteolin to Design Possible Allosteric CDK1/CYCLIN B1 Inhibitors That Overcome Breast Cancer Stemness. | Pharmaceuticals (Basel) | 2026 | 42515730 | PubTator, text mining | PubMed |
| An Interpretable Four-Gene Cell-Cycle Signature Links Malignant Progression to Adverse Survival in Adult Primary Diffuse Glioma: A CGGA Transcriptome Study. | Genes (Basel) | 2026 | 42510873 | PubTator, text mining | PubMed |
| Delafloxacin suppresses DEPDC1 expression and induces G2/M arrest in non-small cell lung cancer cells: A drug repurposing study. | Smart Mol | 2026 | 42500733 | PubTator, text mining | PubMed |
| Identification and validation of stemness-associated hub genes in cervical cancer: a bioinformatics and experimental study. | World J Surg Oncol | 2026 | 42365339 | PubTator, text mining | PubMed |
| Identification of genes differentially expressed in granulosa cells from women with high vs. low ovarian responsiveness. | Front Reprod Health | 2026 | 42358728 | PubTator, text mining | PubMed |
1 to 10 of 2,908
See all 2,908 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/9133
GET https://conductscience.org/api/genes/v1/9133/patents?page=2